摘要
微小RNA(MicroRNAs,mi RNAs)是真核生物中一类长度约为21到23个核苷酸的非编码小分子单链RNA。mi RNA通过与靶m RNA 3′UTR(3′-untranslated region,3′非编码区)完全或不完全结合,抑制翻译或直接诱导其降解,发挥转录后负调控作用。mi RNA参与机体多种生理和病理过程,且可通过调控其靶标基因参与各种信号通路,影响血管生成。mi R-378属于诸多mi RNAs中的一种。目前已知mi R-378的研究主要集中在肿瘤发生及血管生成、心血管疾病和脑缺血等病理过程,其中与肿瘤发生及血管生成相关研究居多。mi R-378在不同肿瘤中的发挥的作用也不一样,在脑胶质瘤,肺癌,横纹肌肉瘤等肿瘤中发挥促癌基因的作用,在卵巢癌,胃癌,大肠癌等肿瘤中发挥抑癌基因的作用。但是,mi R-378调节肿瘤血管生成的作用机制还有待于深入研究。本文主要对mi R-378在四种肿瘤(脑胶质瘤、肺腺癌、卵巢癌和横纹肌肉瘤)中调控血管生成的相关性研究进展进行综述,以期为这些疾病的治疗和预防提供一种新的思路。
MicroRNAs(mi RNAs) are non-coding small-molecule single-stranded RNAs of approximately 21 to 23 nucleotides in length in eukaryotes. The mi RNA inhibits translation or directly induces degradation by completely or incompletely binding to the target m RNA 3'UTR(3'-untranslated region, 3' non-coding region), and exerts a negative post-transcriptional regulation. Numerous studies have shown that mi RNAs participate in a variety of physiological and pathological processes in the body, and can affect angiogenesis by regulating their target genes to participate in signaling pathways. MiR-378 is one of the families of mi RNAs. At present,mi R-378 is mainly studied in the pathogenesis of tumorigenesis and angiogenesis, cardiovascular disease and cerebral ischemia, and most of the studies related to tumorigenesis and angiogenesis. MiR-378 plays a different role in different tumor tissues, and plays a role as a tumor-promoting gene in glioma, lung cancer, rhabdomyosarcoma, etc., and acts as a tumor suppressor gene in tumors such as ovarian cancer, gastric cancer, colorectal cancer. However, the mechanism by which miR-378 regulates tumor angiogenesis remains to be further studied. This study mainly introduces the progress of miR-378 in the regulation of angiogenesis in four tumors(glioma, lung adenocarcinoma, ovarian cancer and rhabdomyosarcoma), providing a new idea for the treatment and prevention of these diseases.
引文
[1]Folkman J.Angiogenesis[J].Journal of Biological Chemistry,1992,267(16):1-18
[2]Xu Y,Yuan FE,Chen QX,et al.Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas[J].Glioma,2018,1(2):35
[3]Ofek P,Tiram G,Satchifainaro R.Angiogenesis regulation by nanocarriers bearing RNA interference[J].Advanced Drug Delivery Reviews,2017,119:3-19
[4]Meiyu LU,Zhong W,Chunfeng SI,et al.Tumor angiogenesis and tumor vascular-targeted drug:research advances[J].Anhui Medical&Pharmaceutical Journal,2018
[5]MarméD.Tumor angiogenesis:a key target for cancer thera py[J].Oncology Research&Treatment,2018,41(4)
[6]Moreirasoares M,Coimbra R,Rebelo L,et al.Angiogenic Factors produced by Hypoxic Cells are a leading driver of Anastomoses in Sprouting Angiogenesis-a computational study[J].Scientific Reports,2018,8(1)
[7]Xie Y,Qi Y,Zhang Y,et al.Regulation of angiogenic factors by the PI3K/Akt pathway in A549 lung cancer cells under hypoxic conditions[J].Oncology Letters,2017,13(5):2909-2914
[8]Kareva I.Chapter 4-Blood vessel formation and pathological angiogenesis as mitigated by competing angiogenesis regulators[J].Understanding Cancer from A Systems Biology Point of View,2018:45-60
[9]Pauty J,Usuba R,Cheng IG,et al.A vascular endothelial growth factor-dependent sprouting angiogenesis assay based on an in vitro human blood vessel model for the study of anti-angiogenic drugs[J].Ebiomedicine,2018,27:225-236
[10]Khalil S,Yendala R,D'Cunha N,et al.Giant-cell tumor of bone with pathological evidence of blood vessel invasion[J].Hematology oncology&Stem Cell Therapy,2017,10(3):161
[11]Ronca R,Benkheil M,Mitola S,et al.Tumor angiogenesis revisited:regulators and clinical implications[J].Medicinal Research Reviews,2017,37
[12]Stylianopoulos T,Munn LL,Jain RK.Reengineering the tumor vasculature:improving drug delivery and efficacy[J].Trends in Cancer,2018,4(4):258
[13]Carmeliet P,Jain RK.Angiogenesis in cancer and other diseases[J].Nature,2000,407(6801):249
[14]You WK,Stallcup WB.Localization of VEGF to vascular ECM is an important aspect of tumor angiogenesis[J].Cancers,2017,9(8):97
[15]Kang EB,Lee GB,In I,et al.PH-sensitive fluorescent hyaluronic acid nanogels for tumor-targeting and controlled delivery of doxorubicin and nitric oxide[J].European Polymer Journal,2018,101
[16]Rasheduzzaman M,Moon JH,Lee JH,et al.Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAILin lung cancer via inhibition of autophagy flux[J].International Journal of Biochemistry&Cell Biology,2018
[17]Rabender CS,Bruno N,Alam A,et al.Sepiapterin enhances tumor radio and chemosensitivities by promoting vascular normalization[J].Journal of Pharmacology&Experimental Therapeutics,2018,365(3):jpet.117.245258
[18]Wang F,Xia X,Yang C,et al.SMAD4 gene mutation renders pancreatic cancer resistance to radiotherapy through promotion of autophagy[J].Clin Cancer Res,2018,24(13):3176-3185
[19]Croce CM.Causes and consequences of microRNA dysregulation in cancer[J].Cancer Journal,2012,48(3):215-222
[20]Wu W.MicroRNA,noise,and gene expression regulation[J].Methods Mol Biol,2018:91-96
[21]Zhao H,Kuang L,Wang L,et al.Prediction of microRNA-disease associations based on distance correlation set[J].Bmc Bioinformatics,2018,19(1):141
[22]Liu Q,Zhang L,Li H.New Insights:microRNA function in CNSdevelopment and psychiatric diseases[J].Current Pharmacology Reports,2018,4(7006):1-13
[23]Motti ML,D'Angelo S,Meccariello R.MicroRNA,cancer and diet:facts and new exciting perspectives[J].Curr Mol Pharmacol,2018,10
[24]Krist B,Florczyk U,Pietraszek-Gremplewicz K,et al.The role of miR-378a in metabolism,angiogenesis,and muscle biology[J].International Journal of Endocrinology,2015,(2015-12-29),2015,2015(2,part 1):1-13
[25]Molinapinelo S,Gutiérrez G,Pastor MD,et al.MicroRNA-dependent regulation of transcription in non-small cell lung cancer[J].Plos One,2014,9(3):e90524
[26]Naixin D,Xin JS,Ting TW,et al.miR-378a-3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10[J].International Journal of Molecular Medicine,2018,42:381-391
[27]张秀敏,于波,李学渊.过表达miR-378骨髓间充质干细胞移植治疗心肌梗死[J].中国组织工程研究,2017,21(9):1390-1396
[28]Yuan J,Liu H,Gao W,et al.MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress[J].Theranostics,2018,8(9):2565-2582
[29]Sun M,Yamashita T,Shang J,et al.Time-dependent profiles of microRNA expression induced by ischemic preconditioning in the gerbil hippocampus[J].Cell Transplantation,2015,24(3):367-376
[30]钟洁,李洁霏,郭颖,等.miR-378负性调节caspase-3蛋白表达减轻氧-糖剥夺致小鼠N2A细胞缺血损伤[J].基础医学与临床,2013,33(11):1446-1451
[31]Zhang N,Zhong J,Han S,et al.MicroRNA-378 alleviates cerebral ischemic injury by negatively regulating apoptosis executioner caspase-3[J].International Journal of Molecular Sciences,2016,17(9):1427
[32]Ambros V.The functions of animal microRNAs[J].Nature,2004,431(7006):350-355
[33]Zielaksteciwko AE,Browne JA.How to explore the function and importance of microRNAs:microRNAs expression profile and their target/pathway prediction in bovine ovarian cells[J].Methods in Molecular Biology,2018,1733:93
[34]Zhang Y,Yun Z,Gong L,et al.Comparison of miRNA evolution and function in plants and animals[J].Microrna,2018,7(1):4
[35]Fabbri M.MicroRNAs and mi-rceptors:a new mechanism of action for intercellular communication[J].Philos Trans R Soc Lond B Biol Sci,2018,373(1737):20160486
[36]Xu Y,Yuan FE,Chen QX,et al.Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas[J].Glioma,2018,1(2):35-42
[37]Li LY.Targeting tumor vasculature for anti-cancer therapy[J].Clinical Journal of Cancer Biotherm,2001,8(3):163-3167
[38]Folkman J.Angiogenesis in cancer,vascular,rheumatoid and other disease[J].Nature Medicine,1995,1(1):27-31
[39]Bauer AJ,Terrell R,Doniparthi NK,et al.Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice[J].Thyroid Official Journal of the American Thyroid Association,2002,12(11):953
[40]Yaguang Hu,Xi Lu,Yue Xu,et al.Salubrinal attenuated retinal neovascularization by inhibiting CHOP-HIF-1α-VEGF pathways[J].Oncotarget,2017,8(44):77219-77232
[41]Tang J,Xia J,Zhang X.The relationship between the level of serum HIF-1α,MMP-2 and VEGF and clinical features in patients with non-small cell lung cancer[J].Chinese Journal of Clinical Rational Drug Use,2018
[42]Ai P,Shen B,Pan H,et al.MiR-411 suppressed vein wall fibrosis by downregulating MMP-2 via targeting HIF-1α[J].Journal of Thrombosis&Thrombolysis,2018,45(2):264-273
[43]Liu G,Liu L,Pathology DO.Expression of HIF-1αand MMP-2 in gastric cancer and their clinicopathological significance[J].Contemporary Medicine,2018
[44]Lam Y,Lecce L,Ng M.Androgens enhance ischaemia-mediated neovascularisation by stimulation of HIF-1αand endothelial progenitor cell(EPC)mobilisation[J].Heart Lung&Circulation,2013,22(Suppl 1):S12-S12
[45]Lee YA,Choi HM,Lee SH,et al.Hypoxia differentially affects IL-β-stimulated MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an HIF-1α-dependent manner[J].Rheumatology,2012,51(3):443-450
[46]朱振浩,陈家乐,伍丽青,等.miRNA参与的血管内皮生长因子及其信号通路调控在肿瘤血管生成中作用的研究进展[J].广东医学,2016,37(1):136-139
[47]Banys-Paluchowski M,Witzel I,Riethdorf S,et al.The clinical relevance of serum vascular endothelial growth factor(VEGF)in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer[J].Breast Cancer Research&Treatment,2018,15(02):1-12
[48]Bagheri A,Kumar P,Kamath A,et al.Association of angiogenic cytokines(VEGF-A and VEGF-C)and clinical characteristic in women with unexplained recurrent miscarriage[J].Bratislavske Lekarske Listy,2017,118(5):258
[49]左慧,李丽.在恶性肿瘤中检测MMPs、TIMPs的研究进展[J].中国临床医学,2003,10(1):95-97
[50]Belotti D,Paganoni P,Manenti L,et al.Matrix metalloproteinases(MMP9 and MMP2)induce the release of vascular endothelial growth factor(VEGF)by ovarian carcinoma cells:implications for ascites formation[J].Cancer Research,2003,63(17):5224-5229
[51]钟思思,辛柳燕,郑永亮,等.miR-378与肿瘤的研究进展[J].中国老年学,2015(24):7253-7256
[52]Velazqueztorres G,Shoshan E,Ivan C,et al.A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVAexpression[J].Nature Communications,2018,9(1):461
[53]Tang X,Zhou J,Zhang J,et al.Low expression of FUS1 is negatively correlated with miR-378 and may predict adverse prognoses in acute myeloid leukemia[J].Acta Haematologica,2018,139(2):89
[54]Ji KX,Cui F,Qu D,et al.MiR-378 promotes the cell proliferation of non-small cell lung cancer by inhibiting FOXG1[J].European Review for Medical&Pharmacological Sciences,2018,22(4):1011
[55]尤永平.我国脑胶质瘤基础研究与转化现状与进展[J].南京医科大学学报(自然科学版),2018,(1):1
[56]Shalijiangaierken,Cai L,Neurosurgery DO.Research progress of microRNA in gliomas[J].Systems Medicine,2018
[57]Shi C,Lamba N,Zheng LJ,et al.Depression and survival of glioma patients:a systematic review and meta-analysis[J].Clinical Neurology&Neurosurgery,2018,172:8
[58]Guishard AF,Yakisich JS,Azad N,et al.Translational gap in ongoing clinical trials for glioma[J].Journal of Clinical Neuroscience Official Journal of the Neurosurgical Society of Australasia,2018,47:28
[59]Van AW,Senders JT,Martin E,et al.Clinical challenges of glioma and pregnancy:a systematic review[J].Journal of Neuro-Oncology,2018,(6):1-11
[60]Lee DY,Deng Z,Wang CH,et al.MicroRNA-378 promotes cell survival,tumor growth,and angiogenesis by targeting Su Fu and Fus-1expression[J].Proceedings of the National Academy of Sciences of the United States of America,2007,104(51):20350
[61]Li W,Liu Y,Yang W,et al.MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma[J].Journal of Neuro-Oncology,2017,136(Suppl 4):1-9
[62]Nagase T,Nagase M,Yoshimura K,et al.Angiogenesis within the developing mouse neural tube is dependent on sonic hedgehog signaling:possible roles of motor neurons[J].Genes to Cells,2005,10(6):595-604
[63]Pola R,Ling LE,Silver M,et al.The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors[J].Nature Medicine,2001,7(6):706-711
[64]Lavine KJ,White AC,Park C,et al.Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development[J].Genes Dev,2006,20(12):1651-1666
[65]Hua Z,Lv Q,Ye W,et al.MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia[J].Plos One,2006,1(1):e116
[66]杨丽颖,陈平.肺癌死亡率增加冬季雾霾不容小觑[J].家庭医学(下半月),2018(1):50-51
[67]Wang Y.Clinical study of compound kushen injection combined with chemotherapy on advancednon-small cell lung cancer[J].China Journal of Chinese Medicine,2015
[68]Toriyama M,Tagaya E,Yamamoto T,et al.Lung cancer development in the patient with granulomatosis with polyangiitis during long term treatment with cyclophosphamide:first documented case[J].Respirology Case Reports,2018,6(2):e00284
[69]Wang S,Lian X,Sun M,et al.Efficacy of compound Kushen injection plus radiotherapy on nonsmall-cell lungcancer:A systematic review and meta-analysis[J].Journal of Cancer Research&Therapeutics,2016,12(4):1298
[70]Chen LT,Xu SD,Xu H,et al.MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration,invasion and tumor angiogenesis[J].Medical Oncology,2012,29(3):1673-1680
[71]Chai SH,Noor SM,Nagoor NH.MiR-378 and miR-1827 regulate tumor invasion,migration and angiogenesis in human lung adenocarcinoma by targeting RBX1 and CRKL,respectively[J].Journal of Cancer,2018,9(2):331
[72]Skrzypek K,Tertil M,Golda S,et al.HO-1 and miR-378 regulate tumor microenvironment and angiogenic potential of human lung cancer[J].Vascular Pharmacology,2012,56(5-6):369-369
[73]Wasti AT,Mandeville H,Gatz S,et al.Rhabdomyosarcoma[J].Paediatrics&Child Health,2018,28(4)
[74]El DD,Mcgowan-Jordan J,De NJ,et al.Update on molecular findings in rhabdomyosarcoma[J].Pathology,2017,49(3)
[75]Russo I,Paolo VD,Gurnari C,et al.Congenital rhabdomyosarcoma:a different clinical presentation in two cases[J].Bmc Pediatrics,2018,18(1):166
[76]Missiaglia E,Shepherd C J,Aladowicz E,et al.MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas[J].Cancer Letters,2017,385:251-260
[77]冯晨,唐锁勤,黄东生,等.儿童横纹肌肉瘤8例临床分析[J].中国实用儿科杂志,2005,20(5):297-299
[78]Skrzypek K,Kusienicka A,Szewczyk B,et al.Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression[J].Oncotarget,2015,6(31):31378-31398
[79]狄文,胡媛.卵巢癌的大数据研究[J].中国实用妇科与产科杂志,2018,34(1):18-22
[80]Lorusso D,Tripodi E,Maltese G,et al.Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer:design,development and place in therapy[J].Drug Design Development&Therapy,2018,12:1501-1509
[81]Torre LA,Trabert B,Desantis CE,et al.Ovarian cancer statistics,2018[J].Histopathology,2018
[82]Chan JK,Kiet TK,Blansit K,et al.MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer[J].Gynecologic Oncology,2014,133(3):568-574